Cellular and humoral immune responses against cancer: implications for cancer vaccines
- 31 October 1991
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 3 (5), 659-664
- https://doi.org/10.1016/0952-7915(91)90093-g
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Tumor-cell-targeted cytokine gene therapyImmunology Today, 1991
- The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.The Journal of Experimental Medicine, 1991
- Lymphokine gene therapy for cancerImmunology Today, 1990
- Antigens recognized on a melanoma cell line by autologous cytolytic T lymphocytes are also expressed on freshly collected tumor cellsEuropean Journal of Immunology, 1990
- Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.The Journal of Experimental Medicine, 1990
- Presence on a human melanoma of multiple antigens recognized by autologous CTLInternational Journal of Cancer, 1989
- Clonal analysis of the cytolytic T-cell response to human tumorsImmunology Today, 1987
- The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptidesCell, 1986
- Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.The Journal of Experimental Medicine, 1983
- Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.The Journal of Experimental Medicine, 1983